1. Home
  2. Volume 24 Number 3, October 2024
  3. DANIEL

Multi-drug resistance-1 (MDR-1) gene expression in MCF-7 cells after treated with doxorubicin-deoxyelephantopin combination and prediction of inhibitory activity against Pgp receptors with in silico

DANIEL DANIEL, FRENGKI FRENGKI, MUHAMMAD JALALUDDIN, WAHYU EKA SARI, ROSMAIDAR ROSMAIDAR, HASRIATI HASRIATI, NONI ZAKIAH

Abstract


Doxorubicin chemotherapy has been a strong focus in breast cancer research. Side effects, toxicity and resistance have been extensively studied. One proposed solution to these issues that its combination with deoxyelephantopin. Deoxyelephantopin is known to be toxic in many cancer cells but safe in normal cells. IC50 of each compound were determined by using a MTT assay, and the MDR-1 gene mRNA expression were determined by using qPCR method, while the interaction of doxorubicin in combination with deoxyelephantonin on Pgp receptor were predicted by using an in silico approach. The IC50 of deoxyelephantopin was found to be 11.2 µg/mL, while IC50 of doxorubicin was 448 nM IC50 values showed a deoxyelephantopin-doxorubicin combination was able to reduce MDR-1 expression by 19% compared to doxorubicin and ½ IC50 values indicated that the combination formula reduced the expression by 15% over doxorubicin alone. The affinity of doxorubicin and deoxyelephantopin is -12.16 kcal/mol and -9.51 kcal/mol, respectively, while the affinity of doxorubicin after combine with deoxyelephantopin decreases from -12,16 kcal/mol to -11,25 kcal/mol due to the release of one Leu 221 hydrogen bond. The combination of doxorubicin with deoxyelephantopin is able to reduce expression and suppress the function of the Pgp protein.

Keywords


deoxyelephantopin, doxorubicin, MCF-7 cell line, Pgp resceptors

References


Juliano, RL.; and Ling, V. 1976. A Surface Glycoprotein Modulating Drug Permeability in Chinese Hamster Ovary Cell Mutants. Biochim Biophys Acta. 455(1) 152-162.

Katayama, K.; Noguchi, K.; and Sugimoto, Y. 2014. Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells. Review. New Journal Science. 2014(2) 1-10

Li, Y.; Li, S.; Han, Y.; Liu, J.; Zhang, J.; Li, F.; Wang, Y. 2008. Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Eur J Pharmacol. 2008(591) 252–258

Nakagami, H.; Soukupová, H.; Schikora, A. 2006. A Mitogen-activated proteinkinase kinase kinase mediates reactive oxygen species homeostasis in Arabidopsis. J Biol Chem.2006 (281) 38697–38704.

Kuo, MT.; Liu, Z.; Wei, Y.; Lin-Lee, YC.; Tatebe, S.; Mills, GB.; Unat,e H. 2002. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling. Oncogene. 2002(21) 1945–1954

McCubrey, JA.; Steelman, LS.; Steelman, LS.; Chappell, WH.; Abrams, SL.; Wong, EW. 2006. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul. 2006(46) 249-279

Zhou, J.; Liu, M.; Aneja, R.; Chandra, R.; Lage, H.; and Joshi, HC. 2006. Reversal of P-glycoprotein Mediated Multidrug Resistance in Cancer Cells by The c-Jun-NH2 Terminal Kinase. Cancer Res. 2006(66) 445

Sukhai, M.; and Piquette-Miller, M. 2000. Regulation of Multidrug Resistance Genes by Stress Signals. J Pham Pharmaceutical Science. 3(2) 268-280

Cox, J.; and Weinmann S, 2016. Mechanism of Doxorubicin Resistance in Hepatocellular Carcinoma. Hepat Oncol. 3(1) 57-59. Doi: 10.2217/hep/15.41

Bentires-Alj, M.; Barbu, V.; Fillet, M.; Chariot, A.; Relic, B.; Jacobs, N. 2003. NFkB Transcription Factor Induces Drugs Resistance Through MDR1 Expression in Cancer Cells. Oncogen. 2003(22) 90-97

Sui H, Fan Z-Z, Li Q. 2012. Signal Transduction Pathway and Transcriptional Mechanism of ABCB1/Pgp-Mediated Multiple Drug Resistance in Human Cancer Cells. The Journal International Medical Research; 40: 426-235

Shiddiqa, AM.; Long, L.; Li, L.; Marciniak, RA.; Kazhdan, I. 2008. Expression of HER-2 in MCF-7 Breast Cancer Cells Modulates anti-Apoptotic Protein Survivin and BcL-2 via The Extracellular Signal-Related Kinase (ERK) and Phosphoinositide-3 Kinase (PI3K) Signaling Pathway. BMC Cancer. 2008(8) 129. Doi: 10.1186/1471-2407-8-129.

Marklein, D.; Graab, U.; Naumann, I.; Yan, T.; Ridzewski, R.; Nitzki, F.; Rosenberger, A. 2012. PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells. PloS ONE. 7(12) doi:10.1371/jounal.pone.0052898

Flory, S.; Männle, R.; & Frank, J. 2021. The Inhibitory Activity of Curcumin on P-Glycoprotein and Its Uptake by and Efflux from LS180 Cells Is Not Affected by Its Galenic Formulation. Antioxidants (Basel, Switzerland) 10(11) 1826 https://doi.org/10.3390/antiox10111826

Miller, CJ.; & Turk, BE. 2018. Homing in: Mechanisms of Substrate Targeting by Protein Kinases. Trends in biochemical sciences. 43(5) 380–394. https://doi.org/10.1016/j.tibs.2018.02.009

Geetha, BS.; Mangalam, SN.; Latha, PG.; Remani, P. 2012. Sesquiterpne lactone isolated from E.Scaber L, inhibites himan lymphocyte proliferation and the growth of tumor cell lines and induces apoptosis in vitro. J Biomed Biotechnol. 2012(721285). Doi: 10.1155/2012/721285.

Kabeer, FA.; Rajalekshmi, DS.; Nair, MS.; Prathapan, R. 2017. Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells. Integr Med Res. 2017(6) 190-206

Liang, QL.; Min, ZD.; Tang, YP. 2008. A new elemanolide sesquiterpene lactone from Elephantopus scaber. Journal of Asian Natural Products Research. 2008(10) 403-407

Su, M.; Wu, X.; Chung, HY.; Li, Y.; Ye, W. 2009. Antiproliferative activities of five Chinese medicinal herbs and active compounds in Elephantophus scaber. Natural Product Communication. 4(8) 1025-1030

Xu, G.; Liang, Q.; Gong, Z.; Yu, W.; He, S.; Xi, L. 2006. Antitumor activities of the four sesquiterpene lactonee from E.Scaber L. Exp Oncol. 28(2) 106-109

Schmittgen, TD.; Livak, KJ. 2008. Analyzing real‐time PCR data by the comparative CT method. Nat Protoc. 2008(3) 1101– 1108.

KAPA Biosystems. 2013. KAPA SYBR FAST qPCR kit Master Mix (2x) ABI Prism Technical Data Sheet. Boston: KAPA BIO

Vatanavicharn, T.; Prapavorarat, A.; Jaree, P.; Somboonwiwat, K.; Tassanakajon, A. 2014. PmVRP15, a novel viral responsive protein from the black tiger shrimp, Penaeus monodon, promoted white spot syndrome virus replication.PLoS ONE. 9(3) e91930. doi:10.1371/journal.pone.0091930

Davis, JM.; Navolanic, PM.; Weinstein-Oppenheimer, CR.; Steelman, LS.; Wei, H.; Konopleva. 2003. Raf-1 and Bcl-2 Induce Distinct and Common Pathways That Contribute to Breast Cancer Drug Resistance. Clin. Canc. Res. (9) 1161-1170.

Frengki, Deddi, PP.; Wahyuni, FS.; Khambri, D.; Sofia, V. 2021 The effect of Deoxyelephantopin enhances Doxorubicin Sensitivity to MCF-7 Cancer Cells. Research Journal of Pharmacy and Technology. 14(5) 27915. Doi: 10.52711/0974-360X.2021.00492

Shyur, LF. 2012. Use of Deoxyelephantopin (DET) and analogues thereof for treatment of melanoma. United State Patent No. US 2012/0045519A1

di-Cera E. 2020. Mechanisms of ligand binding. Biophysics reviews. 1(1) 011303. https://doi.org/10.1063/5.0020997

Simstein, R.; Burow, M.; Parker, A.; Weldon, C.; & Beckman, B. (2003). Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Experimental biology and medicine (Maywood, N.J.) 228(9), 995–1003. https://doi.org/10.1177/153537020322800903


Full Text: PDF

DOI: 10.24815/jn.v24i3.33237

Refbacks

  • There are currently no refbacks.